Radiopharm Theranostics Ltd (RADX) Total Liabilities (2024 - 2025)
Radiopharm Theranostics (RADX) posted quarterly Total Liabilities of $279292.7 for Q2 2025, down 5.15% year-over-year from $294472.3 in Q2 2024, and down 5.15% quarter-over-quarter from $294472.3 in Q2 2024.
Radiopharm Theranostics Ltd (RADX) Total Liabilities (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Total Liabilities for 2 consecutive years, with $279292.7 the latest figure, recorded in Q2 2025.
- In Q2 2025, Total Liabilities fell 5.15% year-over-year to $279292.7; the TTM figure through Jun 2025 stood at $279292.7 (down 5.15% YoY), while the FY2025 annual figure was $43.6 million, down 2.4% from the prior year.
- Total Liabilities retreated to $279292.7 in Q2 2025 per RADX's latest filing, from $294472.3 in the prior quarter.
- Across five years, Total Liabilities topped out at $294472.3 in Q2 2024 and bottomed at $279292.7 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 279,292.74 |
| Jun 30, 2024 | 294,472.30 |